These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 10457590

  • 41. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP.
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [Abstract] [Full Text] [Related]

  • 42. [Immunosuppressive therapy in clinical practice].
    Frey FJ.
    Schweiz Med Wochenschr; 1987 May 23; 117(21):810-5. PubMed ID: 3589636
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Long-term outcome of kidney transplantation after steroid withdrawal.
    Dunn T, Asolati M, Holman D, Raofi V, Lutrin F, Massad M, Pollak R, Benedetti E.
    Transplant Proc; 1998 Aug 23; 30(5):1788-9. PubMed ID: 9723283
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The uvea.
    Aronson SB.
    Arch Ophthalmol; 1969 May 23; 81(5):730-48. PubMed ID: 4891040
    [No Abstract] [Full Text] [Related]

  • 47. An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids.
    Charpentier B.
    Transplant Proc; 2001 Jun 23; 33(4 Suppl):3S-10S. PubMed ID: 11406262
    [No Abstract] [Full Text] [Related]

  • 48. The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
    Dukes M, Chan WC, Willoughby DA.
    J Pathol; 1973 Feb 23; 109(2):151-61. PubMed ID: 4720908
    [No Abstract] [Full Text] [Related]

  • 49. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H, Fricke R, Kruli P.
    Rev Clin Esp; 1970 Mar 23; 116(6):539-48. PubMed ID: 4996836
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
    Goebel JC, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A.
    Br J Ophthalmol; 2011 Feb 23; 95(2):209-13. PubMed ID: 20584711
    [Abstract] [Full Text] [Related]

  • 53. Recent advances in the study of uveitis.
    Perkins ES.
    Br J Ophthalmol; 1974 Apr 23; 58(4):462-7. PubMed ID: 4606986
    [No Abstract] [Full Text] [Related]

  • 54. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX, Ciancio G, Burke GW, Roth D, Miller J.
    Clin Transplant; 1997 Oct 23; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [Abstract] [Full Text] [Related]

  • 55. Immunosuppressive drugs in rheumatoid arthritis.
    Baum J, Vaughan J.
    Ann Intern Med; 1969 Jul 23; 71(1):202-4. PubMed ID: 4892968
    [No Abstract] [Full Text] [Related]

  • 56. Immunosuppressive therapy for severe chronic uveitis.
    Andrasch RH, Pirofsky B, Burns RP.
    Arch Ophthalmol; 1978 Feb 23; 96(2):247-51. PubMed ID: 629670
    [Abstract] [Full Text] [Related]

  • 57. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F, Campinchi R, Bloch-Michel E.
    J Fr Ophtalmol; 1982 Feb 23; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract] [Full Text] [Related]

  • 58. Immunotherapy in renal diseases.
    Kher A, Kher V.
    Med Clin North Am; 2012 May 23; 96(3):545-64, x. PubMed ID: 22703855
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.